NASDAQ:FLDM - Fluidigm Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$5.73 +0.03 (+0.53 %)
(As of 05/27/2018 04:00 PM ET)
Previous Close$5.73
Today's Range$5.53 - $5.74
52-Week Range$2.52 - $8.38
Volume84,229 shs
Average Volume168,387 shs
Market Capitalization$222.99 million
P/E Ratio-4.82
Dividend YieldN/A
Beta3.01

About Fluidigm (NASDAQ:FLDM)

Fluidigm logoFluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell genomics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments and consumables, including IFCs, assays, and reagents to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.

Receive FLDM News and Ratings via Email

Sign-up to receive the latest news and ratings for FLDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNASDAQ:FLDM
CUSIP34385P10
Phone650-266-6000

Debt

Debt-to-Equity Ratio3.38
Current Ratio2.40
Quick Ratio1.95

Price-To-Earnings

Trailing P/E Ratio-4.82
Forward P/E Ratio-6.37
P/E GrowthN/A

Sales & Book Value

Annual Sales$101.94 million
Price / Sales2.19
Cash FlowN/A
Price / CashN/A
Book Value$1.25 per share
Price / Book4.58

Profitability

EPS (Most Recent Fiscal Year)($1.19)
Net Income$-60,530,000.00
Net Margins-55.66%
Return on Equity-98.85%
Return on Assets-12.49%

Miscellaneous

Employees505
Outstanding Shares38,920,000

Fluidigm (NASDAQ:FLDM) Frequently Asked Questions

What is Fluidigm's stock symbol?

Fluidigm trades on the NASDAQ under the ticker symbol "FLDM."

How were Fluidigm's earnings last quarter?

Fluidigm Co. (NASDAQ:FLDM) released its quarterly earnings data on Thursday, May, 3rd. The medical research company reported ($0.34) earnings per share for the quarter, beating analysts' consensus estimates of ($0.41) by $0.07. The medical research company earned $25.25 million during the quarter, compared to analyst estimates of $25.40 million. Fluidigm had a negative net margin of 55.66% and a negative return on equity of 98.85%. View Fluidigm's Earnings History.

When is Fluidigm's next earnings date?

Fluidigm is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Fluidigm.

What price target have analysts set for FLDM?

1 brokers have issued twelve-month target prices for Fluidigm's shares. Their predictions range from $6.10 to $6.10. On average, they anticipate Fluidigm's share price to reach $6.10 in the next year. View Analyst Ratings for Fluidigm.

Who are some of Fluidigm's key competitors?

Who are Fluidigm's key executives?

Fluidigm's management team includes the folowing people:
  • Mr. Stephen Christopher Linthwaite, Pres, CEO & Director (Age 45)
  • Mr. Gajus V. Worthington, Co-Founder and Consultant (Age 48)
  • Mr. Vikram Jog, CFO & Principal Accounting Officer (Age 62)
  • Mr. Nicholas S. Khadder, Sr. VP, Gen. Counsel & Corp. Sec. (Age 44)
  • Mr. Steven C. McPhail, Chief Commercial Officer (Age 64)

Has Fluidigm been receiving favorable news coverage?

News stories about FLDM stock have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Fluidigm earned a daily sentiment score of 0.04 on Accern's scale. They also gave media headlines about the medical research company an impact score of 48.39 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are Fluidigm's major shareholders?

Fluidigm's stock is owned by a number of of retail and institutional investors. Top institutional investors include LEVIN CAPITAL STRATEGIES, L.P. (32.20%), Levin Capital Strategies L.P. (24.96%), PRIMECAP MANAGEMENT COMPANY (14.94%), Neuberger Berman Group LLC (11.62%), BlackRock Inc. (5.69%) and Millennium Management LLC (1.01%). Company insiders that own Fluidigm stock include Evan/ Fa Jones, Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite and Steven Mcphail. View Institutional Ownership Trends for Fluidigm.

Which institutional investors are selling Fluidigm stock?

FLDM stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC. View Insider Buying and Selling for Fluidigm.

Which institutional investors are buying Fluidigm stock?

FLDM stock was bought by a variety of institutional investors in the last quarter, including Levin Capital Strategies L.P., Millennium Management LLC, Trexquant Investment LP, BlackRock Inc., Engineers Gate Manager LP, New York State Common Retirement Fund and Wells Fargo & Company MN. Company insiders that have bought Fluidigm stock in the last two years include Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite and Steven Mcphail. View Insider Buying and Selling for Fluidigm.

How do I buy shares of Fluidigm?

Shares of FLDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fluidigm's stock price today?

One share of FLDM stock can currently be purchased for approximately $5.73.

How big of a company is Fluidigm?

Fluidigm has a market capitalization of $222.99 million and generates $101.94 million in revenue each year. The medical research company earns $-60,530,000.00 in net income (profit) each year or ($1.19) on an earnings per share basis. Fluidigm employs 505 workers across the globe.

How can I contact Fluidigm?

Fluidigm's mailing address is 7000 Shoreline Court Suite 100, South San Francisco CA, 94080. The medical research company can be reached via phone at 650-266-6000.


MarketBeat Community Rating for Fluidigm (FLDM)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  363 (Vote Outperform)
Underperform Votes:  199 (Vote Underperform)
Total Votes:  562
MarketBeat's community ratings are surveys of what our community members think about Fluidigm and other stocks. Vote "Outperform" if you believe FLDM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLDM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fluidigm (NASDAQ:FLDM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Fluidigm in the last 12 months. Their average twelve-month price target is $6.10, suggesting that the stock has a possible upside of 6.46%. The high price target for FLDM is $6.10 and the low price target for FLDM is $6.10. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.002.002.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.10$6.10$6.10$9.00
Price Target Upside: 6.46% upside5.54% upside5.54% upside44.69% upside

Fluidigm (NASDAQ:FLDM) Consensus Price Target History

Price Target History for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ:FLDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018Piper Jaffray CompaniesReiterated RatingHold$6.10HighView Rating Details
2/9/2017Cantor FitzgeraldSet Price TargetBuy$9.00N/AView Rating Details
8/5/2016MizuhoBoost Price TargetBuy$11.00 ➝ $12.00N/AView Rating Details
6/1/2016Deutsche BankInitiated CoverageBuyN/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Fluidigm (NASDAQ:FLDM) Earnings History and Estimates Chart

Earnings by Quarter for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ:FLDM) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.9 EPS
Next Year EPS Consensus Estimate: $-0.72 EPS

Fluidigm (NASDAQ FLDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2018        
5/3/2018Q1 2018($0.41)($0.34)$25.40 million$25.25 millionViewN/AView Earnings Details
2/8/2018Q4 2017($0.25)($0.27)$27.14 million$27.75 millionViewListenView Earnings Details
11/2/2017Q3 2017($0.37)($0.31)$25.50 million$24.75 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.60)($0.58)$23.50 million$23.90 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.64)($0.41)$25.00 million$25.53 millionViewN/AView Earnings Details
2/8/2017Q4 2016($0.61)($0.61)$25.91 million$25.10 millionViewListenView Earnings Details
11/3/2016Q3($0.67)($0.68)$27.75 million$22.20 millionViewN/AView Earnings Details
8/4/2016Q2($0.58)($0.64)$29.62 million$28.20 millionViewN/AView Earnings Details
5/5/2016Q116($0.53)($0.40)$26.95 million$29.00 millionViewN/AView Earnings Details
2/4/2016Q4 2015($0.48)($0.38)$30.10 million$30.72 millionViewN/AView Earnings Details
10/29/2015Q315($0.55)($0.15)$27.54 million$28.60 millionViewListenView Earnings Details
8/6/2015Q215($0.48)($0.53)$30.43 million$28.62 millionViewListenView Earnings Details
5/7/2015Q115($0.40)($0.39)$30.70 million$26.70 millionViewListenView Earnings Details
2/5/2015Q414($0.43)($0.39)$33.34 million$33.50 millionViewListenView Earnings Details
10/30/2014Q314($0.04)($0.49)$29.20 million$29.60 millionViewN/AView Earnings Details
7/31/2014Q214($0.50)($0.45)$27.13 million$27.60 millionViewN/AView Earnings Details
5/5/2014Q1 2014($0.31)($0.19)$21.01 million$25.72 millionViewN/AView Earnings Details
2/6/2014Q413($0.15)($0.04)$20.73 million$20.90 millionViewN/AView Earnings Details
10/30/2013Q313($0.20)($0.06)$16.70 million$18.30 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.17)($0.07)$15.87 million$17.50 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.21)($0.21)$14.49 million$14.54 millionViewN/AView Earnings Details
2/12/2013Q4 2012($0.15)($0.14)ViewN/AView Earnings Details
11/7/2012Q312($0.21)($0.12)$13.35 million$12.60 millionViewN/AView Earnings Details
8/7/2012Q2 2012($0.25)($0.22)ViewN/AView Earnings Details
5/10/2012Q1 2012($0.26)($0.25)ViewN/AView Earnings Details
2/14/2012Q4 2011($0.21)($0.17)ViewN/AView Earnings Details
11/8/2011Q3 2011($0.23)($0.22)ViewN/AView Earnings Details
8/9/2011Q2 2011($0.22)($0.21)ViewN/AView Earnings Details
5/10/2011Q1 2011($0.28)($0.35)ViewN/AView Earnings Details
3/9/2011Q4 2010($1.25)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Fluidigm (NASDAQ:FLDM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Fluidigm (NASDAQ FLDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.20%
Institutional Ownership Percentage: 96.29%
Insider Trading History for Fluidigm (NASDAQ:FLDM)
Institutional Ownership by Quarter for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ FLDM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/8/2018Levin Capital Strategies, L.P.InsiderBuy77,700$5.54$430,458.00View SEC Filing  
5/4/2018Levin Capital Strategies, L.P.InsiderBuy92,205$5.69$524,646.45View SEC Filing  
4/30/2018Levin Capital Strategies, L.P.InsiderBuy6,649$5.92$39,362.08View SEC Filing  
4/25/2018Levin Capital Strategies, L.P.InsiderBuy3,700$5.93$21,941.00View SEC Filing  
4/19/2018Levin Capital Strategies, L.P.InsiderBuy10,013$5.92$59,276.96View SEC Filing  
4/2/2018Levin Capital Strategies, L.P.InsiderBuy7,240$5.73$41,485.20View SEC Filing  
3/26/2018Levin Capital Strategies, L.P.InsiderBuy21,020$5.83$122,546.60View SEC Filing  
3/23/2018Levin Capital Strategies, L.P.InsiderBuy7,720$5.97$46,088.40View SEC Filing  
3/8/2018Levin Capital Strategies, L.P.InsiderBuy40,000$6.48$259,200.00View SEC Filing  
3/5/2018Levin Capital Strategies, L.P.InsiderBuy7,500$6.17$46,275.00View SEC Filing  
3/2/2018Levin Capital Strategies, L.P.InsiderBuy250,355$6.25$1,564,718.75View SEC Filing  
2/28/2018Levin Capital Strategies, L.P.InsiderBuy13,950$6.82$95,139.00View SEC Filing  
2/15/2018Levin Capital Strategies, L.P.InsiderBuy10,000$7.86$78,600.00View SEC Filing  
2/7/2018Levin Capital Strategies, L.P.InsiderBuy53,610$5.73$307,185.30View SEC Filing  
2/5/2018Levin Capital Strategies, L.P.InsiderBuy50,987$5.96$303,882.52View SEC Filing  
2/1/2018Levin Capital Strategies, L.P.InsiderBuy152,891$6.18$944,866.38View SEC Filing  
1/23/2018Levin Capital Strategies, L.P.InsiderBuy6,871$6.57$45,142.47View SEC Filing  
1/16/2018Levin Capital Strategies, L.P.InsiderBuy887$6.68$5,925.16View SEC Filing  
1/10/2018Levin Capital Strategies, L.P.InsiderBuy100,576$6.34$637,651.84View SEC Filing  
1/3/2018Levin Capital Strategies, L.P.InsiderBuy29$6.63$192.27View SEC Filing  
12/29/2017Levin Capital Strategies, L.P.InsiderBuy11,230$5.94$66,706.20View SEC Filing  
12/28/2017Levin Capital Strategies, L.P.InsiderBuy30$5.82$174.60View SEC Filing  
12/27/2017Levin Capital Strategies, L.P.InsiderBuy27,100$5.88$159,348.00View SEC Filing  
12/15/2017Levin Capital Strategies, L.P.InsiderBuy24,175$5.84$141,182.00View SEC Filing  
12/12/2017Levin Capital Strategies, L.P.InsiderBuy18,569$5.84$108,442.96View SEC Filing  
12/4/2017Levin Capital Strategies, L.P.InsiderBuy8,409$5.48$46,081.32View SEC Filing  
11/29/2017Levin Capital Strategies, L.P.InsiderBuy20,380$5.71$116,369.80View SEC Filing  
11/17/2017Levin Capital Strategies, L.P.InsiderBuy6,880$5.05$34,744.00View SEC Filing  
11/8/2017Levin Capital Strategies, L.P.InsiderBuy54,900$5.26$288,774.00View SEC Filing  
10/25/2017Levin Capital Strategies, L.P.InsiderBuy4,227$5.42$22,910.34View SEC Filing  
10/23/2017Levin Capital Strategies, L.P.InsiderBuy22,363$5.47$122,325.61View SEC Filing  
10/19/2017Levin Capital Strategies, L.P.InsiderBuy60,000$4.55$273,000.00View SEC Filing  
10/17/2017Levin Capital Strategies, L.P.InsiderBuy144,200$4.59$661,878.00View SEC Filing  
10/10/2017Levin Capital Strategies, L.P.InsiderBuy95,843$4.57$438,002.51View SEC Filing  
10/9/2017Levin Capital Strategies, L.P.InsiderBuy50,000$4.59$229,500.00View SEC Filing  
9/12/2017Levin Capital Strategies, L.P.InsiderBuy60,000$5.25$315,000.00View SEC Filing  
8/17/2017Levin Capital Strategies, L.P.InsiderBuy465$3.66$1,701.90View SEC Filing  
8/10/2017Levin Capital Strategies, L.P.InsiderBuy4,003,129$3.30$13,210,325.70View SEC Filing  
8/9/2017Levin Capital Strategies, L.P.InsiderBuy1,549$3.18$4,925.82View SEC Filing  
8/8/2017Samuel D ColellaDirectorBuy35,895$2.77$99,429.1545,197View SEC Filing  
8/8/2017Stephen Christopher LinthwaiteCEOBuy45,000$2.66$119,700.00106,977View SEC Filing  
8/8/2017Steven McphailInsiderBuy20,000$3.00$60,000.0027,842View SEC Filing  
6/7/2017Evan/ Fa JonesDirectorSell10,900$4.54$49,486.00View SEC Filing  
5/9/2017Samuel D ColellaDirectorBuy7,500$5.93$44,475.0043,523View SEC Filing  
3/14/2017Samuel D ColellaDirectorBuy10,000$5.00$50,000.0043,523View SEC Filing  
12/14/2016Samuel D ColellaDirectorBuy5,000$7.39$36,950.0044,123View SEC Filing  
11/30/2016Samuel D ColellaDirectorBuy20,000$6.32$126,400.0019,123View SEC Filing  
11/30/2016Stephen Christopher LinthwaiteCEOBuy55,000$6.36$349,800.0058,000View SEC Filing  
11/7/2016Levin Capital Strategies, L.P.InsiderBuy159,200$4.44$706,848.00View SEC Filing  
11/2/2016Levin Capital Strategies, L.P.InsiderBuy48,302$4.44$214,460.88View SEC Filing  
10/1/2015Gajus Vincent WorthingtonCEOSell6,000$8.05$48,300.006,815View SEC Filing  
9/2/2015Gajus Vincent WorthingtonCEOSell12,000$11.53$138,360.006,815View SEC Filing  
6/16/2015Vikram JogCFOSell3,550$25.00$88,750.00View SEC Filing  
6/15/2015William Maxwell SmithEVPSell3,000$24.20$72,600.00View SEC Filing  
6/1/2015Gajus Vincent WorthingtonCEOSell6,000$23.71$142,260.00View SEC Filing  
4/20/2015Mai Chan YowInsiderSell15,300$44.73$684,369.00View SEC Filing  
4/17/2015Mai Chan YowInsiderSell4,700$44.04$206,988.00View SEC Filing  
4/17/2015William Maxwell SmithEVPSell3,000$43.05$129,150.00View SEC Filing  
4/8/2015Mai Chan YowInsiderSell30,000$42.67$1,280,100.00View SEC Filing  
4/7/2015Vikram JogCFOSell3,950$40.81$161,199.50View SEC Filing  
4/1/2015Gajus Vincent WorthingtonCEOSell6,000$40.02$240,120.00View SEC Filing  
4/1/2015Robert C JonesEVPSell3,000$41.63$124,890.00View SEC Filing  
3/16/2015William Maxwell SmithEVPSell3,000$40.87$122,610.00View SEC Filing  
3/9/2015Vikram JogCFOSell3,950$41.48$163,846.00View SEC Filing  
3/2/2015Evan/ Fa JonesDirectorSell7,500$44.15$331,125.00View SEC Filing  
3/2/2015Gajus Vincent WorthingtonCEOSell6,000$43.77$262,620.00View SEC Filing  
3/2/2015Robert C JonesEVPSell3,000$43.78$131,340.00View SEC Filing  
2/20/2015Samuel D ColellaDirectorSell44,540$38.97$1,735,723.80View SEC Filing  
2/2/2015Gajus Vincent WorthingtonCEOSell6,000$38.15$228,900.00View SEC Filing  
1/15/2015William Maxwell SmithEVPSell3,000$34.24$102,720.00View SEC Filing  
1/2/2015Gajus Vincent WorthingtonCEOSell6,000$33.37$200,220.00View SEC Filing  
12/15/2014William Maxwell SmithEVPSell3,000$27.20$81,600.00View SEC Filing  
12/12/2014Evan/ Fa JonesDirectorSell8,352$27.44$229,178.88View SEC Filing  
12/9/2014Evan/ Fa JonesDirectorSell3,336$28.34$94,542.24View SEC Filing  
12/8/2014Evan/ Fa JonesDirectorSell1,000$29.06$29,060.00View SEC Filing  
12/8/2014Vikram JogCFOSell3,950$29.07$114,826.50View SEC Filing  
12/1/2014Gajus Vincent WorthingtonCEOSell6,000$30.03$180,180.00View SEC Filing  
11/17/2014William Maxwell SmithEVPSell3,000$29.52$88,560.00View SEC Filing  
11/12/2014Evan/ Fa JonesDirectorSell5,000$29.55$147,750.00View SEC Filing  
11/7/2014Vikram JogCFOSell3,950$29.45$116,327.50View SEC Filing  
10/24/2014Mai Chan YowInsiderSell10,000$28.00$280,000.00View SEC Filing  
10/7/2014Vikram JogCFOSell3,950$22.65$89,467.50View SEC Filing  
9/15/2014William Maxwell SmithEVPSell3,000$30.83$92,490.00View SEC Filing  
9/8/2014Vikram JogCFOSell3,950$28.57$112,851.50View SEC Filing  
9/2/2014Gajus Vincent WorthingtonCEOSell6,000$28.16$168,960.00View SEC Filing  
8/7/2014Vikram JogCFOSell3,733$26.34$98,327.22View SEC Filing  
8/6/2014Gajus Vincent WorthingtonCEOSell6,000$26.53$159,180.00View SEC Filing  
7/15/2014William Maxwell SmithEVPSell3,000$31.98$95,940.00View SEC Filing  
7/7/2014Vikram JogCFOSell5,427$30.61$166,120.47View SEC Filing  
7/1/2014Gajus Vincent WorthingtonCEOSell6,000$29.72$178,320.00View SEC Filing  
6/16/2014William Maxwell SmithEVPSell3,000$27.64$82,920.00View SEC Filing  
6/2/2014Gajus Vincent WorthingtonCEOSell6,000$26.55$159,300.00View SEC Filing  
5/15/2014William Maxwell SmithEVPSell3,000$28.53$85,590.00View SEC Filing  
5/8/2014Gajus Vincent WorthingtonCEOSell6,000$32.14$192,840.00View SEC Filing  
4/15/2014William Maxwell SmithEVPSell3,000$35.32$105,960.00View SEC Filing  
4/7/2014Vikram JogCFOSell5,091$37.51$190,963.41View SEC Filing  
3/17/2014William Maxwell SmithEVPSell3,000$47.76$143,280.00View SEC Filing  
11/6/2013Gajus Vincent WorthingtonCEOSell11,832$30.03$355,314.96View SEC Filing  
9/3/2013Gajus Vincent WorthingtonCEOSell10,000$20.53$205,300.00View SEC Filing  
9/3/2013William Maxwell SmithEVPSell7,000$20.42$142,940.00View SEC Filing  
8/30/2013Robert JonesEVPSell3,500$20.36$71,260.00View SEC Filing  
8/14/2013Samuel ColellaDirectorSell23,192$19.91$461,752.722,631View SEC Filing  
8/8/2013William Maxwell SmithEVPSell16,000$20.02$320,320.00View SEC Filing  
8/6/2013Gajus Vincent WorthingtonCEOSell10,000$19.49$194,900.00View SEC Filing  
8/6/2013Robert JonesEVPSell3,500$19.16$67,060.00View SEC Filing  
7/8/2013Vikram JogCFOSell5,661$17.05$96,520.05View SEC Filing  
7/1/2013Gajus Vincent WorthingtonCEOSell10,000$17.14$171,400.00View SEC Filing  
7/1/2013William Maxwell SmithEVPSell5,000$17.11$85,550.00View SEC Filing  
6/28/2013Robert C JonesEVPSell3,500$17.11$59,885.00View SEC Filing  
6/7/2013Vikram JogCFOSell5,661$16.00$90,576.00View SEC Filing  
6/3/2013Gajus Vincent WorthingtonCEOSell10,000$17.00$170,000.00View SEC Filing  
6/3/2013William Maxwell SmithInsiderSell5,000$16.96$84,800.00View SEC Filing  
5/31/2013Robert C JonesEVPSell3,500$16.93$59,255.00View SEC Filing  
3/4/2013Mai Chan YowInsiderSell30,000$18.15$544,500.00View SEC Filing  
2/4/2013Robert C JonesEVPSell6,984$16.61$116,004.24View SEC Filing  
2/1/2013Gajus Vincent WorthingtonCEOSell10,000$16.60$166,000.00View SEC Filing  
12/28/2012William Maxwell SmithInsiderSell4,504$14.11$63,551.44View SEC Filing  
12/26/2012William Maxwell SmithInsiderSell6,756$14.36$97,016.16View SEC Filing  
12/14/2012Evan/ Fa JonesDirectorBuy10,000$14.36$143,600.00View SEC Filing  
12/11/2012Evan/ Fa JonesDirectorBuy1,971$14.00$27,594.00View SEC Filing  
12/5/2012William Maxwell SmithEVPSell6,756$14.25$96,273.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Fluidigm (NASDAQ FLDM) News Headlines

Source:
DateHeadline
Fluidigm (FLDM) Raised to Buy at Zacks Investment ResearchFluidigm (FLDM) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - May 17 at 12:04 AM
Pacific Biosciences (PACB) versus Fluidigm (FLDM) Financial SurveyPacific Biosciences (PACB) versus Fluidigm (FLDM) Financial Survey
www.americanbankingnews.com - May 15 at 9:08 PM
Fluidigm (FLDM) versus Bruker (BRKR) Head-To-Head SurveyFluidigm (FLDM) versus Bruker (BRKR) Head-To-Head Survey
www.americanbankingnews.com - May 15 at 10:46 AM
Integra lifesciences (IART) & Fluidigm (FLDM) Critical ContrastIntegra lifesciences (IART) & Fluidigm (FLDM) Critical Contrast
www.americanbankingnews.com - May 13 at 5:29 AM
Free Research Report as Thermo Fisher Scientific’s Quarterly Revenue Surged 23%; Adjusted EPS Jumped 20%Free Research Report as Thermo Fisher Scientific’s Quarterly Revenue Surged 23%; Adjusted EPS Jumped 20%
finance.yahoo.com - May 11 at 9:47 AM
Fluidigm to Participate in Upcoming Investor EventsFluidigm to Participate in Upcoming Investor Events
finance.yahoo.com - May 9 at 4:50 PM
Insider Buying: Fluidigm Co. (FLDM) Insider Buys 77,700 Shares of StockInsider Buying: Fluidigm Co. (FLDM) Insider Buys 77,700 Shares of Stock
www.americanbankingnews.com - May 9 at 4:21 PM
Fluidigm (FLDM) Downgraded by ValuEngineFluidigm (FLDM) Downgraded by ValuEngine
www.americanbankingnews.com - May 8 at 3:29 PM
Levin Capital Strategies, L.P. Acquires 92,205 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Acquires 92,205 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - May 7 at 7:38 PM
-$0.22 EPS Expected for Fluidigm Co. (FLDM) This Quarter-$0.22 EPS Expected for Fluidigm Co. (FLDM) This Quarter
www.americanbankingnews.com - May 5 at 9:32 AM
Fluidigm (FLDM) Announces  Earnings ResultsFluidigm (FLDM) Announces Earnings Results
www.americanbankingnews.com - May 4 at 3:26 PM
Fluidigm misses by $0.02, misses on revenueFluidigm misses by $0.02, misses on revenue
seekingalpha.com - May 4 at 9:00 AM
Fluidigms (FLDM) CEO Stephen Linthwaite on Q1 2018 Results - Earnings Call TranscriptFluidigm's (FLDM) CEO Stephen Linthwaite on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 9:00 AM
Edited Transcript of FLDM earnings conference call or presentation 3-May-18 9:00pm GMTEdited Transcript of FLDM earnings conference call or presentation 3-May-18 9:00pm GMT
finance.yahoo.com - May 4 at 9:00 AM
Fluidigm: 1Q Earnings SnapshotFluidigm: 1Q Earnings Snapshot
finance.yahoo.com - May 4 at 9:00 AM
Fluidigm (FLDM) Raised to "Sell" at ValuEngineFluidigm (FLDM) Raised to "Sell" at ValuEngine
www.americanbankingnews.com - May 4 at 12:12 AM
BRIEF-Fluidigm Corp Q1 Revenue $25.2 MillionBRIEF-Fluidigm Corp Q1 Revenue $25.2 Million
www.reuters.com - May 3 at 4:43 PM
Fluidigm Announces First Quarter Financial Results and Operational ProgressFluidigm Announces First Quarter Financial Results and Operational Progress
finance.yahoo.com - May 3 at 4:43 PM
Fluidigm Co. (FLDM) Insider Levin Capital Strategies, L.P. Purchases 6,649 SharesFluidigm Co. (FLDM) Insider Levin Capital Strategies, L.P. Purchases 6,649 Shares
www.americanbankingnews.com - May 2 at 10:31 PM
Insider Buying: Fluidigm Co. (FLDM) Insider Acquires 3,700 Shares of StockInsider Buying: Fluidigm Co. (FLDM) Insider Acquires 3,700 Shares of Stock
www.americanbankingnews.com - April 26 at 7:32 PM
Fluidigm (FLDM) to Release Earnings on ThursdayFluidigm (FLDM) to Release Earnings on Thursday
www.americanbankingnews.com - April 26 at 1:20 AM
Fluidigm Co. (FLDM) Insider Buys $59,276.96 in StockFluidigm Co. (FLDM) Insider Buys $59,276.96 in Stock
www.americanbankingnews.com - April 24 at 7:50 PM
Brad Kreger Joins Fluidigm as Senior Vice President, Global OperationsBrad Kreger Joins Fluidigm as Senior Vice President, Global Operations
finance.yahoo.com - April 23 at 8:51 AM
Has Fluidigm Corporation (NASDAQ:FLDM) Improved Earnings Growth In Recent Times?Has Fluidigm Corporation (NASDAQ:FLDM) Improved Earnings Growth In Recent Times?
finance.yahoo.com - April 20 at 9:14 AM
Fluidigm to Report Q1 2018 Financial Results and Host Conference CallFluidigm to Report Q1 2018 Financial Results and Host Conference Call
finance.yahoo.com - April 19 at 4:56 PM
Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical ResearchFluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research
finance.yahoo.com - April 13 at 4:48 PM
Fluidigm Releases CFTR Next-Generation Sequencing Library Prep Assay for Use With the Juno SystemFluidigm Releases CFTR Next-Generation Sequencing Library Prep Assay for Use With the Juno System
finance.yahoo.com - April 12 at 9:53 AM
Fluidigm (FLDM) Upgraded to "Sell" at ValuEngineFluidigm (FLDM) Upgraded to "Sell" at ValuEngine
www.americanbankingnews.com - April 6 at 11:39 AM
Levin Capital Strategies, L.P. Acquires 7,240 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Acquires 7,240 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - April 4 at 4:16 PM
Comparing HTG Molecular Diagnostics (HTGM) & Fluidigm (FLDM)Comparing HTG Molecular Diagnostics (HTGM) & Fluidigm (FLDM)
www.americanbankingnews.com - April 1 at 11:06 PM
Head-To-Head Survey: Fluidigm (FLDM) versus BioSig Technologies (BSGM)Head-To-Head Survey: Fluidigm (FLDM) versus BioSig Technologies (BSGM)
www.americanbankingnews.com - March 31 at 5:16 AM
Levin Capital Strategies, L.P. Buys 7,720 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Buys 7,720 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - March 27 at 10:50 PM
Levin Capital Strategies, L.P. Acquires 21,020 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Acquires 21,020 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - March 27 at 10:50 PM
Fluidigm (FLDM) Stock Rating Lowered by ValuEngineFluidigm (FLDM) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - March 25 at 6:25 PM
What Investors Should Know About Fluidigm Corporation’s (NASDAQ:FLDM) Financial StrengthWhat Investors Should Know About Fluidigm Corporation’s (NASDAQ:FLDM) Financial Strength
finance.yahoo.com - March 13 at 9:18 AM
Levin Capital Strategies, L.P. Acquires 40,000 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Acquires 40,000 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - March 12 at 7:57 PM
Fluidigm Co. (FLDM) Insider Purchases $46,275.00 in StockFluidigm Co. (FLDM) Insider Purchases $46,275.00 in Stock
www.americanbankingnews.com - March 6 at 9:58 PM
Insider Buying: Fluidigm Co. (FLDM) Insider Purchases 250,355 Shares of StockInsider Buying: Fluidigm Co. (FLDM) Insider Purchases 250,355 Shares of Stock
www.americanbankingnews.com - March 5 at 9:11 PM
Fluidigm Announces Exchange of Convertible NotesFluidigm Announces Exchange of Convertible Notes
finance.yahoo.com - March 2 at 9:01 AM
Fuller & Thaler Asset Management Inc. Cuts Position in Fluidigm Co. (FLDM)Fuller & Thaler Asset Management Inc. Cuts Position in Fluidigm Co. (FLDM)
www.americanbankingnews.com - March 2 at 7:00 AM
Levin Capital Strategies, L.P. Acquires 13,950 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Acquires 13,950 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - March 1 at 10:28 PM
What Should Investors Know About The Future Of Fluidigm Corporation’s (NASDAQ:FLDM) Business?What Should Investors Know About The Future Of Fluidigm Corporation’s (NASDAQ:FLDM) Business?
finance.yahoo.com - February 27 at 5:19 PM
BidaskClub Downgrades Fluidigm (FLDM) to BuyBidaskClub Downgrades Fluidigm (FLDM) to Buy
www.americanbankingnews.com - February 24 at 1:28 PM
Levin Capital Strategies, L.P. Buys 10,000 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Buys 10,000 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - February 20 at 9:46 PM
Fluidigm (FLDM) Raised to "Strong-Buy" at BidaskClubFluidigm (FLDM) Raised to "Strong-Buy" at BidaskClub
www.americanbankingnews.com - February 19 at 3:56 PM
Fluidigm to Participate in Upcoming Health Care Investor ConferencesFluidigm to Participate in Upcoming Health Care Investor Conferences
finance.yahoo.com - February 14 at 5:00 PM
Free Post Earnings Research Report: Thermo Fisher’s Quarterly Revenue Surged 22%; Adjusted EPS Advanced 16%Free Post Earnings Research Report: Thermo Fisher’s Quarterly Revenue Surged 22%; Adjusted EPS Advanced 16%
finance.yahoo.com - February 14 at 9:24 AM
Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational ProgressFluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress
finance.yahoo.com - February 9 at 9:26 AM
Piper Jaffray Companies Reaffirms "Hold" Rating for Fluidigm (FLDM)Piper Jaffray Companies Reaffirms "Hold" Rating for Fluidigm (FLDM)
www.americanbankingnews.com - February 9 at 12:54 AM
Fluidigm (FLDM) Releases  Earnings Results, Beats Expectations By $0.17 EPSFluidigm (FLDM) Releases Earnings Results, Beats Expectations By $0.17 EPS
www.americanbankingnews.com - February 9 at 12:52 AM

SEC Filings

Fluidigm (NASDAQ:FLDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Fluidigm (NASDAQ:FLDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fluidigm (NASDAQ FLDM) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.